UCARTSUpper Cumberland Area Rural Transit System (Tennessee)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
This approach has both clinical and operational benefits: the UCART is designed to have a lymphodepleting effect, and the CAR T-cell cross reaction is suppressed, allowing for successful manufacturing.
Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART).